A Novel Approach to Neuroprotection - advancing a new therapy to treat concussion, TBI or stroke. Email: social@astrocytepharma.com
Location: United States, Massachusetts, Cambridge
Total raised: $6M
Investors 3
| Date | Name | Website |
| - | Life Scien... | lifescienc... |
| - | SideCar An... | sidecarang... |
| - | K2X | k2x.capita... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 21.08.2023 | Series A | $6M | - |
Mentions in press and media 7
| Date | Title | Description |
| 12.03.2024 | Astrocyte Pharmaceuticals Announces FDA Clearance of its Investigational New Drug Application for AST-004 | - |
| 21.08.2023 | Astrocyte Pharmaceuticals Raises $6M in Pre-Series B Financing | Astrocyte Pharmaceuticals, a Cambridge, MA-based Groton, CT-based clinical-stage drug discovery and development company, raised $6M in Pre-Series B funding. The round was led by Dreavent Capital, and joined by the Alzheimer’s Drug Discovery... |
| 07.05.2021 | StartUPDATES: New developments from healthcare startups | In a collaboration effort to test whether existing drug candidates block infection from respiratory pathogens like SARS-CoV-2, researchers from the Wyss Institute at Harvard University, the University of Maryland School of Medicine, the Ica... |
| 06.08.2015 | BioMed SA Celebrates 10th Anniversary | By LAURA LOREK Reporter with Silicon Hills News |
| - | Astrocyte Pharmaceuticals | - |
| - | StartUPDATES: New developments from healthcare startups | In a collaboration effort to test whether existing drug candidates block infection from respiratory pathogens like SARS-CoV-2, researchers from the Wyss Institute at Harvard University, the University of Maryland School of Medicine, the Ica... |
| - | Astrocyte Pharmaceuticals | “Harnessing the Potential of Astrocytes to Treat Brain Injuries and Diseases Astrocyte Pharmaceuticals is developing innovative neuroprotection therapies for Traumatic Brain Injuries (TBI), concussions, stroke, and neurodegenerative disorde... |